Body mass index (BMI) is a predictor for response to neoadjuvant chemotherapy in women with localized breast cancer aged 35 years or younger.

被引:0
作者
Eralp, Y
Smith, TL
Kau, SW
Valero, V
Buzdar, A
Hortobagyi, GN
Arun, B
机构
[1] Istanbul Univ, Inst Oncol, Istanbul, Turkey
[2] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
600
引用
收藏
页码:27S / 27S
页数:1
相关论文
empty
未找到相关数据